注册 | 登录 | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuh's Parving [33 articles]

当前文献位于 jyuh's 文献库中 作者 Parving. 你也可以 see everyone's Parving.
  • Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
    N Engl J Med, Vol. 348, No. 5. (30 January 2003), pp. 383-393.
    by P Gaede, P Vedel, N Larsen, GV Jensen, HH Parving, O Pedersen
    posted to steno rct dm cv by jyuh on 2008-10-07 08:37:32 as ** along with 1 person and 1 group worx11 XROWXR
  • Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study.
    Diabetes care, Vol. 31, No. 8. (August 2008), pp. 1510-1515.
    by P Gaede, WJ Valentine, AJ Palmer, DM Tucker, M Lammert, HH Parving, O Pedersen
    posted to steno rct dm cea 1 by jyuh on 2008-10-01 09:56:23 as **
  • Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 42, No. 4. (October 2003), pp. 617-622.
    by G Eknoyan, T Hostetter, GL Bakris, L Hebert, AS Levey, HH Parving, MW Steffes, R Toto
    posted to proteinuria guideline ckd 1 by jyuh on 2008-09-30 13:41:12 as **
  • Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy
    Diabetes Care, Vol. 31, No. 6. (1 June 2008), pp. 1177-1182.
    by Tri Q Nguyen, Lise Tarnow, Anders Jorsal, Noelynn Oliver, Peggy Roestenberg, Yasuhiko Ito, Hans-Henrik Parving, Peter Rossing, Frans A van Nieuwenhoven, Roel Goldschmeding
    posted to mortality hd dn ctgf blood by jyuh on 2008-09-07 10:43:59 as **
  • Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.
    Journal of the American Society of Nephrology : JASN, Vol. 14, No. 11. (November 2003), pp. 2843-2850.
    by P Jacobsen, L Tarnow, B Carstensen, P Hovind, O Poirier, HH Parving
    posted to ace dn snp by jyuh on 2008-08-12 03:50:24 as **
  • Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy.
    Kidney international, Vol. 61, No. 1. (January 2002), pp. 163-168.
    by HP Hansen, P Hovind, BR Jensen, HH Parving
    posted to diurnal dn gfr proteinuria by jyuh on 2008-07-01 11:35:37 as **
  • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
    The New England journal of medicine, Vol. 345, No. 12. (20 September 2001), pp. 861-869.
    by BM Brenner, ME Cooper, D de Zeeuw, WF Keane, WE Mitch, HH Parving, G Remuzzi, SM Snapinn, Z Zhang, S Shahinfar,
    posted to arb dn rct by jyuh on 2008-06-14 07:13:32 as ** along with 1 person djmonstermo
  • Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
    Kidney Int, Vol. 73, No. 12. (12 March 2008), pp. 1419-1425.
    by F Persson, P Rossing, KJ Schjoedt, T Juhl, L Tarnow, CDA Stehouwer, C Schalkwijk, F Boomsma, E Frandsen, HH Parving
    posted to dn ras rct by jyuh on 2008-06-10 11:10:26 as **
  • Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
    N Engl J Med, Vol. 358, No. 23. (5 June 2008), pp. 2433-2446.
    by Hans-Henrik Parving, Frederik Persson, Julia B Lewis, Edmund J Lewis, Norman K Hollenberg, The
    posted to dn ras rct renin by jyuh on 2008-06-05 02:40:19 as ** along with 1 person djmonstermo
  • Long-term prevention of diabetic nephropathy: an audit.
    Diabetologia, Vol. 51, No. 6. (June 2008), pp. 956-961.
    by KJ Schjoedt, HP Hansen, L Tarnow, P Rossing, HH Parving
    posted to dn by jyuh on 2008-05-12 02:30:22 as **
  • ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy
    J Am Soc Nephrol, Vol. 19, No. 4. (1 April 2008), pp. 771-779.
    by Hans-Henrik Parving, Dick de Zeeuw, Mark E Cooper, Giuseppe Remuzzi, Nancy Liu, Jared Lunceford, Shahnaz Shahinfar, Peggy H Wong, Paulette A Lyle, Peter Rossing, Barry M Brenner
    posted to ace dn rct snp by jyuh on 2008-03-31 05:01:17 as **
  • Increased renal gene transcription of protein kinase C-beta in human diabetic nephropathy: relationship to long-term glycaemic control.
    Diabetologia (16 February 2008)
    by R G Langham, D J Kelly, R M Gow, Y Zhang, A J Cox, W Qi, K Thai, C A Pollock, P K Christensen, H-H H Parving, R E Gilbert
    posted to pt pkc hg dn by jyuh on 2008-02-24 06:03:48 as **
  • The Effect of LDL-cholesterol and Treatment with Losartan on End-stage Renal Disease in the RENAAL Study.
    Diabetes Care (10 December 2007)
    by Andrew M M Tershakovec, William F F Keane, Zhongxin Zhang, Paulette A A Lyle, Gerald B B Appel, Janet B B McGill, Hans-Henrik H Parving, Mark E E Cooper, Shahnaz Shahinfar, Barry M M Brenner
    posted to dn hyperlipidemia ras rct by jyuh on 2008-02-14 09:43:53 as **
  • Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes.
    N Engl J Med, Vol. 358, No. 6. (7 February 2008), pp. 580-591.
    by Peter Gæde, Henrik Lund-Andersen, Hans-Henrik H Parving, Oluf Pedersen
    posted to steno rct mortality dm by jyuh on 2008-02-11 09:51:18 as ** along with 2 people scottd2104 omalbam
  • Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.
    J Clin Endocrinol Metab (22 January 2008)
    by Gowsini Joseph, Lise Tarnow, Anne Sofie S Astrup, Troels Krarup K Hansen, Hans-Henrik H Parving, Allan Flyvbjerg, Jan Frystyk
    posted to no-tag by jyuh on 2008-01-27 08:30:37 as **
  • Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    J Hypertens, Vol. 25, No. 12. (December 2007), pp. 2479-2485.
    by Anne S Astrup, Flemming S Nielsen, Peter Rossing, Samir Ali, Jens Kastrup, Ulla M Smidt, Hans-Henrik H Parving
    posted to no-tag by jyuh on 2007-11-23 03:33:45 as **
  • Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.
    Kidney Int, Vol. 69, No. 11. (June 2006), pp. 2057-2063.
    by HH Parving, JB Lewis, M Ravid, G Remuzzi, LG Hunsicker,
    posted to no-tag by jyuh on 2007-11-15 08:20:53 as **
  • The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality
    Journal of Internal Medicine, Vol. 262, No. 4. (October 2007), pp. 470-478.
    by Klausen, , Parving, -H, Scharling, , Jensen,
    posted to uae mortality irs cv ckd by jyuh on 2007-10-02 04:06:05 as **
  • Anaemia in diabetes: Is there a rationale to TREAT?
    Diabetologia, Vol. 49, No. 6. (June 2006), pp. 1151-1157.
    by MC Thomas, ME Cooper, K Rossing, HH Parving
    posted to no-tag by jyuh on 2007-09-19 02:03:20 as **
  • Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies.
    J Hypertens, Vol. 25, No. 4. (April 2007), pp. 871-876.
    by WB Eijkelkamp, Z Zhang, BM Brenner, ME Cooper, RB Devereux, B Dahlöf, H Ibsen, WF Keane, LH Lindholm, MH Olsen, HH Parving, G Remuzzi, S Shahinfar, SM Snapinn, K Wachtell, D de Zeeuw
    posted to no-tag by jyuh on 2007-09-05 06:07:54 as **
  • European rational approach for the genetics of diabetic complications EURAGEDIC: patient populations and strategy.
    Nephrol Dial Transplant (17 August 2007)
    by Lise Tarnow, Per-Henrik H Groop, Samy Hadjadj, Gbenga Kazeem, Francois Cambien, Michel Marre, Carol Forsblom, Hans-Henrik H Parving, David Trégouët, Alexandre Thévard, Martin Farrall, Ivo Gut, Dominique Gauguier, Roger Cox, Fumihiko Matsuda, Mark Lathrop, Nathalie Vionnet,
    posted to dn genetics by jyuh on 2007-08-25 02:58:26 as ** along with 1 person Terkko
  • Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients.
    Diabet Med, Vol. 18, No. 9. (September 2001), pp. 756-760.
    by P Gaede, HE Poulsen, HH Parving, O Pedersen
    posted to no-tag by jyuh on 2007-08-25 02:51:15 as **
  • Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate.
    Nephrol Dial Transplant, Vol. 18, No. 3. (March 2003), pp. 539-542.
    by P Gaede, HP Hansen, HH Parving, O Pedersen
    posted to no-tag by jyuh on 2007-08-25 02:50:41 as **
  • Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy.
    Kidney Int, Vol. 70, No. 3. (August 2006), pp. 536-542.
    by KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, L Tarnow, P Rossing, HH Parving
    posted to dn aldosterone by jyuh on 2007-08-12 03:31:44 as **
  • Glomerular hyperfiltration in microalbuminuric NIDDM patients
    Diabetologia, Vol. 39, No. 12. (4 November 1996), pp. 1584-1589.
    by P Vedel, J Obel, FS Nielsen, LE Bang, TL Svendsen, OB Pedersen, HH Parving
    posted to no-tag by jyuh on 2007-08-07 16:27:04 as **
  • Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
    Nephrol Dial Transplant, Vol. 21, No. 9. (September 2006)
    by P Rossing, HH Parving, D de Zeeuw
    posted to no-tag by jyuh on 2007-08-03 16:59:34 as **
  • Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Nephrol Dial Transplant, Vol. 19, No. 11. (November 2004), pp. 2784-2788.
    by P Gaede, L Tarnow, P Vedel, HH Parving, O Pedersen
    posted to no-tag by jyuh on 2007-08-03 11:46:08 as **
  • Progression of nephropathy in type 2 diabetic patients.
    Kidney Int, Vol. 66, No. 4. (October 2004), pp. 1596-1605.
    by K Rossing, PK Christensen, P Hovind, L Tarnow, P Rossing, HH Parving
    posted to no-tag by jyuh on 2007-08-03 11:43:20 as **
  • Renoprotection: ACE Inhibitors or ARBs Are Essential
    (2006)
    by HH Parving
    posted to no-tag by jyuh on 2007-08-01 08:13:54 as **
  • Microalbuminuria as an early marker for cardiovascular disease.
    J Am Soc Nephrol, Vol. 17, No. 8. (August 2006), pp. 2100-2105.
    by D de Zeeuw, HH Parving, RH Henning
    posted to uae cv by jyuh on 2007-07-29 02:10:51 as **
  • Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.
    Diabetes, Vol. 55, No. 11. (November 2006), pp. 3166-3174.
    by N Vionnet, D Tregouët, G Kazeem, I Gut, PH Groop, L Tarnow, HH Parving, S Hadjadj, C Forsblom, M Farrall, D Gauguier, R Cox, F Matsuda, S Heath, A Thévard, R Rousseau, F Cambien, M Marre, M Lathrop
    posted to no-tag by jyuh on 2007-06-23 04:44:49 as **
  • Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations.
    J Am Soc Nephrol (21 March 2007)
    by Samy Hadjadj, Lise Tarnow, Carol Forsblom, Gbenga Kazeem, Michel Marre, Per-Henrik H Groop, Hans-Henrik H Parving, François Cambien, David A A Tregouet, Ivo G G Gut, Alexandre Théva, Dominique Gauguier, Martin Farrall, Roger Cox, Fumihiko Matsuda, Mark Lathrop, Nathalie Hager-Vionnet
    posted to dn haplotype ras snp by jyuh on 2007-06-14 03:43:29 as ** along with 1 person Terkko
  • Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    J Am Soc Nephrol, Vol. 18, No. 5. (May 2007), pp. 1540-1546.
    by WB Eijkelkamp, Z Zhang, G Remuzzi, HH Parving, ME Cooper, WF Keane, S Shahinfar, GW Gleim, MR Weir, BM Brenner, D de Zeeuw
    posted to dn proteinuria ras rct by jyuh on 2007-06-14 03:36:21 as **
    • ◇温馨提示◇本页的引用地址为： http://www.citeulike.org/user/jyuh/author/Parving

    RIS BibTeX